Human Chorionic Gonadotropin (HCG) Market Report

China Human Chorionic Gonadotropin (HCG) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 10, 2023
  • PAGES：208
  • REPORT CODE：GMM1843131
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

    The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

    This report elaborates on the current development of the Human Chorionic Gonadotropin (HCG) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Leebio

    • Merck & Co, Inc

    • Bristol Myers Squibb Company

    • Scrippslabs

    • Kamiya Biomedical Company

    • Fresenius Kabi AG, LLC

    • Cigna

    • Ferring BV

    • EMD Serono, Inc

    By Type:

    • Natural Source Extraction

    • Recombinant DNA Technology

    By Application:

    • Female Infertility Treatment

    • Cryptorchidism Treatment

    • Oligospermic Treatment

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human Chorionic Gonadotropin (HCG) Market Overview 2018-2029

    • 1.1 China Human Chorionic Gonadotropin (HCG) Industry Development Overview

    • 1.2 China Human Chorionic Gonadotropin (HCG) Industry Development History

    • 1.3 China Human Chorionic Gonadotropin (HCG) Industry Market Size (2018-2029)

    • 1.4 China Human Chorionic Gonadotropin (HCG) Market Analysis by Type from Production Side

      • 1.4.1 China Human Chorionic Gonadotropin (HCG) Production Volume, Production Value and Growth Rate of Natural Source Extraction (2018-2029)

      • 1.4.2 China Human Chorionic Gonadotropin (HCG) Production Volume, Production Value and Growth Rate of Recombinant DNA Technology (2018-2029)

    • 1.5 China Human Chorionic Gonadotropin (HCG) Market Analysis by Application from Consumption End

      • 1.5.1 China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Female Infertility Treatment (2018-2029)

      • 1.5.2 China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Cryptorchidism Treatment (2018-2029)

      • 1.5.3 China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Oligospermic Treatment (2018-2029)

      • 1.5.4 China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Human Chorionic Gonadotropin (HCG) Market Analysis by Region

      • 1.6.1 North China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human Chorionic Gonadotropin (HCG) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human Chorionic Gonadotropin (HCG) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human Chorionic Gonadotropin (HCG) Market Status and Competition Analysis in 2023

      • 2.2.3 China Human Chorionic Gonadotropin (HCG) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human Chorionic Gonadotropin (HCG) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human Chorionic Gonadotropin (HCG) Industry Development

    Chapter 3 Human Chorionic Gonadotropin (HCG)Industry Chain Analysis

    • 3.1 Human Chorionic Gonadotropin (HCG) Industry Chain

    • 3.2 Human Chorionic Gonadotropin (HCG) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human Chorionic Gonadotropin (HCG) Market

    • 3.3 Human Chorionic Gonadotropin (HCG) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human Chorionic Gonadotropin (HCG) Market

    Chapter 4 China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 4.1 China Human Chorionic Gonadotropin (HCG) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human Chorionic Gonadotropin (HCG) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human Chorionic Gonadotropin (HCG) Production Volume and Growth Rate, by Type

      • 4.5.1 China Human Chorionic Gonadotropin (HCG) Production Volume and Growth Rate of Natural Source Extraction

      • 4.5.2 China Human Chorionic Gonadotropin (HCG) Production Volume and Growth Rate of Recombinant DNA Technology

    Chapter 5 China Human Chorionic Gonadotropin (HCG) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human Chorionic Gonadotropin (HCG) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate, by Application

      • 5.5.1 China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Female Infertility Treatment

      • 5.5.2 China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Cryptorchidism Treatment

      • 5.5.3 China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Oligospermic Treatment

      • 5.5.4 China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Others

    Chapter 6 China Human Chorionic Gonadotropin (HCG) Market, by Region

    • 6.1 China Human Chorionic Gonadotropin (HCG) Production Volume and Production Value, by Region

    • 6.2 China Human Chorionic Gonadotropin (HCG) Sales Volume and Sales Value, by Region

    Chapter 7 North China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 7.1 North China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 7.2 North China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 8 Central China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 8.1 Central China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 8.2 Central China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 9 South China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 9.1 South China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 9.2 South China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 10 East China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 10.1 East China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 10.2 East China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 11 Northeast China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 11.1 Northeast China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 11.2 Northeast China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 12 Southwest China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 12.1 Southwest China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 12.2 Southwest China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 13 Northwest China Human Chorionic Gonadotropin (HCG) Market Analysis

    • 13.1 Northwest China Human Chorionic Gonadotropin (HCG) Market, by Type

    • 13.2 Northwest China Human Chorionic Gonadotropin (HCG) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Leebio

        • 14.1.1 Leebio Company Profile

        • 14.1.2 Leebio Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck & Co, Inc

        • 14.2.1 Merck & Co, Inc Company Profile

        • 14.2.2 Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bristol Myers Squibb Company

        • 14.3.1 Bristol Myers Squibb Company Company Profile

        • 14.3.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Scrippslabs

        • 14.4.1 Scrippslabs Company Profile

        • 14.4.2 Scrippslabs Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Kamiya Biomedical Company

        • 14.5.1 Kamiya Biomedical Company Company Profile

        • 14.5.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Fresenius Kabi AG, LLC

        • 14.6.1 Fresenius Kabi AG, LLC Company Profile

        • 14.6.2 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Cigna

        • 14.7.1 Cigna Company Profile

        • 14.7.2 Cigna Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Ferring BV

        • 14.8.1 Ferring BV Company Profile

        • 14.8.2 Ferring BV Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 EMD Serono, Inc

        • 14.9.1 EMD Serono, Inc Company Profile

        • 14.9.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human Chorionic Gonadotropin (HCG) Industry Research Conclusions

    • 15.2 Human Chorionic Gonadotropin (HCG) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human Chorionic Gonadotropin (HCG) Industry Market Size (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Volume, Production Value and Growth Rate of Natural Source Extraction (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Volume, Production Value and Growth Rate of Recombinant DNA Technology (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Female Infertility Treatment (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Cryptorchidism Treatment (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Oligospermic Treatment (2018-2029)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure Central China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure South China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure East China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate from 2018-2029

    • Figure Human Chorionic Gonadotropin (HCG) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human Chorionic Gonadotropin (HCG) Market Share by Type in 2018

    • Figure China Human Chorionic Gonadotropin (HCG) Market Share by Type in 2023

    • Figure China Human Chorionic Gonadotropin (HCG) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Volume and Growth Rate of Natural Source Extraction (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Volume and Growth Rate of Recombinant DNA Technology (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Market Share by Application in 2018

    • Figure China Human Chorionic Gonadotropin (HCG) Market Share by Application in 2023

    • Figure China Human Chorionic Gonadotropin (HCG) Total Market Size and Growth Rate from Consumption End

    • Figure China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Female Infertility Treatment (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Cryptorchidism Treatment (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Oligospermic Treatment (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Others (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Production Volume by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Production Volume Share by Region (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Volume Share by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Production Value by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Production Value Share by Region (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Production Value Share by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Sales Volume by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Region (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Sales Value by Region (2018-2023)

    • Table China Human Chorionic Gonadotropin (HCG) Sales Value Share by Region (2018-2023)

    • Figure China Human Chorionic Gonadotropin (HCG) Sales Value Share by Region (2018-2023)

    • Table North China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table North China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure North China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table North China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table North China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure North China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table Central China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table Central China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure Central China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table Central China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table Central China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure Central China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table South China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table South China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure South China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table South China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table South China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure South China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table East China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table East China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure East China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table East China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table East China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure East China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table Northeast China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table Northeast China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table Northeast China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table Southwest China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table Southwest China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table Southwest China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human Chorionic Gonadotropin (HCG) Production Volume by Type (2018-2023)

    • Table Northwest China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human Chorionic Gonadotropin (HCG) Production Volume Share by Type (2018-2023)

    • Table Northwest China Human Chorionic Gonadotropin (HCG) Sales Volume by Application (2018-2023)

    • Table Northwest China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human Chorionic Gonadotropin (HCG) Sales Volume Share by Application (2018-2023)

    • Table Leebio Company Profile

    • Table Leebio Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Bristol Myers Squibb Company Company Profile

    • Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Scrippslabs Company Profile

    • Table Scrippslabs Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Kamiya Biomedical Company Company Profile

    • Table Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Fresenius Kabi AG, LLC Company Profile

    • Table Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Cigna Company Profile

    • Table Cigna Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table Ferring BV Company Profile

    • Table Ferring BV Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)

    • Table EMD Serono, Inc Company Profile

    • Table EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US